Skip to main content
SpringerLink
Log in
Book cover

Alcoholic/Non-Alcoholic Digestive Diseases pp 23–32Cite as

Post Helicobacter pylori Gastric Diseases

  • Chapter
  • First Online:

  • 308 Accesses

Abstract

A variety of researches have been focused on Helicobacter pylori (H. pylori) in gastroenterological field, and H. pylori has been recognized as etiologically responsible for gastritis-associated peptic ulcers and the majority of gastric cancers. The incidence rate of H. pylori infection is higher in Asian countries including Japan than in Western countries. However, past natural circumstances in Japan suitable for an inhabiting of H. pylori have been improved in parallel with the sanitary developments. In addition, the eradication therapy has been permitted with national insurance to most patients with H. pylori infection in 2013. As a result, the present infection rate is gradually decreasing. Based on the above surrounding environment, an age-depending decrease in acid secretion due to mucosal atrophy caused by chronic H. pylori infection is recently lacking. Therefore, certain acid secretion is continuously maintained with no age relationship. Accordingly, most Japanese physicians must switch their focus to the acid-related diseases (H. pylori-non-associated diseases) from the H. pylori-associated diseases throughout the entire generations.

As post H. pylori gastric diseases, this part will give the information about (1) H. pylori-negative mucosal injury excluding gastric cancer because it is introduced in the next chapter, (2) functional dyspepsia whose pathophysiology is in part associated with mucosal sensitivity to acid exposure, and (3) association of non-alcoholic fatty liver disease with gastroesophageal diseases.

This is a preview of subscription content, log in via an institution.

Chapter
USD   29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD   84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD   109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Learn about institutional subscriptions

References

  1. Warren JR, Marshall BJ. Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet. 1983;1:1273–5.

    CAS  PubMed  Google Scholar 

  2. Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet. 1984;1:1311–5.

    Article  CAS  Google Scholar 

  3. Namekata T, Miki K, Kimmey M, Fritsche T, Hughes D, Moore D, et al. Chronic atrophic gastritis and Helicobacter pylori infection among Japanese Americans in Seattle. Am J Epidemiol. 2000;151:820–30.

    Article  CAS  Google Scholar 

  4. Correa P. Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res. 1992;52:6735–40.

    CAS  PubMed  Google Scholar 

  5. International Agency for Research on Cancer, World Health Organization. Schistosomes, liver flukes and Helicobacter pylori. IARC Monogr Eval Carcinog Risks Hum. 1994;61:177–241.

    Google Scholar 

  6. International Agency for Research on Cancer. Helicobacter pylori. Biologic agents: a review of human carcinogens, vol. 100B. Leon: International Agency for Research on Cancer; 2012. p. 385–435.

    Google Scholar 

  7. Higuchi K, Fujiwara Y, Tominaga K, Watanabe T, Shiba M, Nakamura S, et al. Is eradication sufficient to heal gastric ulcers in patients infected with Helicobacter pylori? A randomized, controlled, prospective study. Aliment Pharmacol Ther. 2003;17:111–7.

    Article  CAS  Google Scholar 

  8. Tsumoto C, Tominaga K, Okazaki H, Tanigawa T, Yamagami H, Watanabe K, et al. Long-term efficacy of Helicobacter pylori eradication in patients with idiopathic thrombocytopenic purpura: 7-year follow-up prospective study. Ann Hematol. 2009;88:789–93.

    Article  CAS  Google Scholar 

  9. Miwa H, Sakaki N, Sugano K, Sekine H, Higuchi K, Uemura N, et al. Recurrent peptic ulcers in patients following successful Helicobacter pylori eradication: a multicenter study of 4940 patients. Helicobacter. 2004;9:9–16.

    Article  Google Scholar 

  10. Fukase K, Kato M, Kikuchi S, Inoue K, Uemura N, Okamoto S, et al. Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial. Lancet. 2008;372:392–7.

    Article  Google Scholar 

  11. Aoyama N, Shinoda Y, Matsushima Y, Shirasaka D, Kinoshita Y, Kasuga M, et al. Helicobacter pylori-negative peptic ulcer in Japan: which contributes most to peptic ulcer development, Helicobacter pylori, NSAIDS or stress? J Gastroenterol. 2000;35(Suppl 12):33–7.

    PubMed  Google Scholar 

  12. Kanno T, Iijima K, Abe Y, Yagi M, Asonuma S, Ohyauchi M, et al. A multicenter prospective study on the prevalence of Helicobacter pylori-negative and nonsteroidal anti-inflammatory drugs-negative idiopathic peptic ulcers in Japan. J Gastroenterol Hepatol. 2015;30:842–8.

    Article  Google Scholar 

  13. Wong GL, Wong VW, Chan Y, Ching JY, Au K, Hui AJ, et al. High incidence of mortality and recurrent bleeding in patients with Helicobacter pylori-negative idiopathic bleeding ulcers. Gastroenterology. 2009;137:525–31.

    Article  Google Scholar 

  14. Hawkey CJ, Tulassay Z, Szczepanski L, van Rensburg CJ, Filipowicz-Sosnowska A, Lanas A, et al. Randomised controlled trial of Helicobacter pylori eradication in patients on non-steroidal anti-inflammatory drugs: HELP NSAIDs study. Helicobacter eradication for lesion prevention. Lancet. 1998;352:1016–21.

    Article  CAS  Google Scholar 

  15. de Leest HT, Steen KS, Lems WF, Bijlsma JW, van de Laar MA, Huisman AM, et al. Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial. Helicobacter. 2007;12:477–85.

    Article  Google Scholar 

  16. Tang CL, Ye F, Liu W, Pan XL, Qian J, Zhang GX. Eradication of Helicobacter pylori infection reduces the incidence of peptic ulcer disease in patients using nonsteroidal anti-inflammatory drugs: a meta-analysis. Helicobacter. 2012;17:286–96.

    Article  CAS  Google Scholar 

  17. Chan FK, Ching JY, Suen BY, Tse YK, Wu JC, Sung JJ. Effects of Helicobacter pylori infection on long-term risk of peptic ulcer bleeding in low-dose aspirin users. Gastroenterology. 2013;144:528–35.

    Article  CAS  Google Scholar 

  18. Kamada T, Haruma K, Ito M, Inoue K, Manabe N, Matsumoto H, et al. Time trends in Helicobacter pylori infection and atrophic gastritis over 40 years in Japan. Helicobacter. 2015;20:192–8.

    Article  Google Scholar 

  19. Haruma K, Kamada T, Kawaguchi H, Okamoto S, Yoshihara M, Sumii K, et al. Effect of age and Helicobacter pylori infection on gastric acid secretion. J Gastroenterol Hepatol. 2000;15:277–83.

    Article  CAS  Google Scholar 

  20. Kinoshita Y, Kawanami C, Kishi K, Nakata H, Seino Y, Chiba T. Helicobacter pylori independent chronological change in gastric acid secretion in the Japanese. Gut. 1997;41:452–8.

    Article  CAS  Google Scholar 

  21. Ishimura N, Owada Y, Aimi M, Oshima T, Kamada T, Inoue K, et al. No increase in gastric acid secretion in healthy Japanese over the past two decades. J Gastroenterol. 2015;50:844–52.

    Article  Google Scholar 

  22. Schuligoi R, Joci M, Heinemann A, Scho¨ninkle E, Pabst MA, Holzer P. Gastric acid–evoked c-fos messenger RNA expression in rat brainstem is signaled by capsaicin-resistant vagal afferents. Gastroenterology. 1998;115:649–60.

    Article  CAS  Google Scholar 

  23. Lamb K, Kang YM, Gebhart GF, Bielefeldt K. Gastric inflammation triggers hypersensitivity to acid in awake rats. Gastroenterology. 2003;125:1410–8.

    Article  Google Scholar 

  24. Miwa H, Nakajima K, Yamaguchi K, Fujimoto K, Veldhuyzen VAN Zanten SJ, et al. Generation of dyspeptic symptoms by direct acid infusion into the stomach of healthy Japanese subjects. Aliment Pharmacol Ther. 2007;26:257–64.

    Article  CAS  Google Scholar 

  25. Oshima T, Okugawa T, Tomita T, Sakurai J, Toyoshima F, Watari J, et al. Generation of dyspeptic symptoms by direct acid and water infusion into the stomachs of functional dyspepsia patients and healthy subjects. Aliment Pharmacol Ther. 2012:175:175–82.

    Article  Google Scholar 

  26. Moayyedi P, Soo S, Deeks J, Delaney B, Innes M, Forman D. Pharmacological interventions for non-ulcer dyspepsia. Cochrane Database Syst Rev. 2006;(5):178–85.

    Google Scholar 

  27. Peura DA, Kovacs TO, Metz DC, Siepman N, Pilmer BL, Talley NJ. Lansoprazole in the treatment of functional dyspepsia: two double-blind, randomized, placebo-controlled trials. Am J Med. 2004;116:740–8.

    Article  CAS  Google Scholar 

  28. van Zanten SV, Armstrong D, Chiba N, Flook N, White RJ, Chakraborty B, et al. Esomeprazole 40 mg once a day in patients with functional dyspepsia: the randomized, placebo-controlled "ENTER" trial. Am J Gastroenterol. 2006;101:2096–106.

    Article  Google Scholar 

  29. Iwakiri R, Tominaga K, Furuta K, Inamori M, Furuta T, Masuyama H, et al. Randomised clinical trial: rabeprazole improves symptoms in patients with functional dyspepsia in Japan. Aliment Pharmacol Ther. 2013;38:729–40.

    Article  CAS  Google Scholar 

  30. Sakurai K, Nagahara A, Inoue K, Akiyama J, Mabe K, Suzuki J, et al. Efficacy of omeprazole, famotidine, mosapride and teprenone in patients with upper gastrointestinal symptoms: an omeprazole-controlled randomized study (J-FOCUS). BMC Gastroenterol. 2012;12:42. https://doi.org/10.1186/1471-230X-12-42.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  31. Sugano K, Tack J, Kuipers EJ, Graham DY, El-Omar EM, Miura S, et al. Kyoto global consensus report on Helicobacter pylori gastritis. Gut. 2015;64:1353–67.

    Article  Google Scholar 

  32. Stanghellini V, Chan FK, Hasler WL, Malagelada JR, Suzuki H, Tack J, et al. Gastroduodenal Disorders. Gastroenterology. 2016;150:1380–92.

    Article  Google Scholar 

  33. Miwa H, Kusano M, Arisawa T, Oshima T, Kato M, Joh T, et al. Evidence-based clinical practice guidelines for functional dyspepsia. J Gastroenterol. 2015;50:125–39.

    Article  CAS  Google Scholar 

  34. Xu H, Barnes GT, Yang Q, Tan G, Yang D, Chou CJ, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest. 2003;112:1821–30.

    Article  CAS  Google Scholar 

  35. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, et al. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37:917–23.

    Article  Google Scholar 

  36. Fujikawa Y, Tominaga K, Fujii H, Machida H, Okazaki H, Yamagami H, et al. High prevalence of gastroesophageal reflux symptoms in patients with non-alcoholic fatty liver disease associated with serum levels of triglyceride and cholesterol but not simple visceral obesity. Digestion. 2012;86:228–37.

    Article  CAS  Google Scholar 

  37. Ledeboer M, Mascle AAM, Biemond I, Lamers CBHW. Effect of medium- and long-chain triglycerides onlower esophageal sphincter pressure: role of CCK. Am J Phys. 1998;274:1160–5.

    Google Scholar 

  38. Trudgill NJ, Riley SA. Tansient lower esophageal sphincter relaxations are no more frequent in patients with gastroesophageal reflux disease than in asymptomatic volunteers. Am J Gastroenterol. 2001;96:2569–74.

    Article  CAS  Google Scholar 

  39. Shapiro M, Green C, Bautista M, Dekel R, Risner-Adler S, Whitacre R, et al. Assessment of dietary nutrients that influence perception of intra-oesophageal acid reflux events in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2007;25:93–101.

    Article  CAS  Google Scholar 

  40. Matsuzaki J, Suzuki H, Iwasaki E, Yokoyama H, Sugino Y, Hibi T. Serum lipid levels are positively associated with non-erosive reflux disease, but not with functional heartburn. Neurogastroenterol Motil. 2010;22:965–70.

    Article  CAS  Google Scholar 

  41. Wu P, Ma L, Dai GX, Chen Y, Tong YL, Wang C, et al. The association of metabolic syndrome with reflux esophagitis: a case-control study. Neurogastroenterol Motil. 2011;23:989–94.

    Article  CAS  Google Scholar 

  42. Schulz MD, Atay C, Heringer J, Romrig FK, Schwitalla S, Aydin B, et al. High-fat-diet-mediated dysbiosis promotes intestinal carcinogenesis independently of obesity. Nature. 2014;514:508–12.

    Article  CAS  Google Scholar 

  43. Hirata Y, Sezaki T, Tamura-Nakano M, Oyama C, Hagiwara T, Ishikawa T, et al. Fatty acids in a high-fat diet potentially induce gastric parietal-cell damage and metaplasia in mice. J Gastroenterol. 2017;52:889–903.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Premier Developmental Research of Medicine, Osaka Medical College, Osaka, Japan

    Kazunari Tominaga

  2. Second Department of Internal Medicine, Osaka Medical College, Osaka, Japan

    Kazunari Tominaga & Kazuhide Higuchi

Authors
  1. Kazunari Tominaga
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Kazuhide Higuchi
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Third Department of Internal Medicine, Nara Medical University, Kashihara, Japan

    Hitoshi Yoshiji

  2. Third Department of Internal Medicine, Nara Medical University, Kashihara, Japan

    Kosuke Kaji

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Singapore Pte Ltd.

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Tominaga, K., Higuchi, K. (2019). Post Helicobacter pylori Gastric Diseases. In: Yoshiji, H., Kaji, K. (eds) Alcoholic/Non-Alcoholic Digestive Diseases. Springer, Singapore. https://doi.org/10.1007/978-981-13-1465-0_3

Download citation

  • DOI: https://doi.org/10.1007/978-981-13-1465-0_3

  • Published:

  • Publisher Name: Springer, Singapore

  • Print ISBN: 978-981-13-1464-3

  • Online ISBN: 978-981-13-1465-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation